Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patients

David Wright, Allen Rodriguez, Eliot Godofsky, Sharon Walmsley, Emily Labriola-Tompkins, Lucille Donatacci, Anna Shikhman, Ernestine Tucker, Yu Yuan Chiu, Jain Chung, Lucy Rowell, Ralph DeMasi, Neil Graham, Miklos Salgo

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patients'. Together they form a unique fingerprint.

Medicine & Life Sciences